Alternate-day dosing of atorvastatin: Effects in treating type 2 diabetic patients with dyslipidaemia

  • Ferrer-García J
  • Pérez-Silvestre J
  • Martínez-Mir I
 et al. 
  • 10

    Readers

    Mendeley users who have this article in their library.
  • 21

    Citations

    Citations of this article.

Abstract

An analysis is made of the effect of alternateday dosing of atorvastatin and standard once-daily dosing, based on mean low-density lipoprotein (LDL) reduction from baseline in type 2 diabetics. Forty-four type 2 diabetics were enrolled in the study. In compliance with American Diabetes Association (ADA) and National Cholesterol Education Program Expert Panel (NCEP-III) guidelines, LDL-C

Author-supplied keywords

  • Atorvastatin
  • Cholesterol
  • Dyslipidaemia
  • Low-density lipoprotein
  • Type 2 diabetes

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • J. C. Ferrer-García

  • J. Pérez-Silvestre

  • I. Martínez-Mir

  • A. Herrera-Ballester

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free